Bristol-Myers Urges Justices To Ax 'Impossible' Patent Rule
Appealing a decision that erased its $1.1 billion victory in a cancer therapy case, a Bristol-Myers unit told the U.S. Supreme Court on Monday the Federal Circuit's requirement that patents demonstrate...To view the full article, register now.
Already a subscriber? Click here to view full article